(Q38460001)

3 September 2017

Correlation of immunohistochemical molecular staging of bladder biopsies and radical cystectomy specimens (English)

1 reference

3 September 2017

0 references

H Tokunaga

1

1 reference

3 September 2017

S F Shariat

2

1 reference

3 September 2017

A E Green

3

1 reference

3 September 2017

R M Brown

4

1 reference

3 September 2017

J H Zhou

5

1 reference

3 September 2017

W F Benedict

6

1 reference

3 September 2017

S P Lerner

7

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

International Journal of Radiation Oncology Biology Physics

3 September 2017

1 reference

3 September 2017

51

1 reference

3 September 2017

16-22

1 reference

3 September 2017

1

1 reference

p53 mutations in human cancers

3 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901586-3

7 January 2021

The p53 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901586-3

7 January 2021

Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901586-3

7 January 2021

p53 mutations in human bladder cancer: genotypic versus phenotypic patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901586-3

7 January 2021

Accumulation of nuclear p53 and tumor progression in bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901586-3

7 January 2021

Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901586-3

7 January 2021

Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901586-3

7 January 2021

Altered Expression of Retinoblastoma Protein and Known Prognostic Variables in Locally Advanced Bladder Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901586-3

7 January 2021

Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901586-3

7 January 2021

Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901586-3

7 January 2021

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901586-3

7 January 2021

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901586-3

7 January 2021

Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901586-3

7 January 2021

p53 and treatment of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901586-3

7 January 2021

Retinoblastoma protein expression and radiation response in muscle-invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901586-3

7 January 2021

Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901586-3

7 January 2021

10.1016/S0360-3016(01)01586-3

Identifiers

DOI

1 reference

3 September 2017

1 reference